A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal Vaccines is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5DP1DA060580-02
Engineering Bacteriophage T4 as a Targeted Gene Therapy Drug for in vivo HIV Cure
National Institutes of Health
Grant: 2R01AI081726-06A1
Structural studies of bacteriophage T4 and their potential medical applications
National Institutes of Health
Grant: 3R01AI095366-08S1
Rapid Generation of Vaccine Candidates Against Novel Coronavirus (SARS-CoV-2) Using the Bacteriophage T4 Nanoparticle Platform
National Institutes of Health
Grant: 1R01AI175340-01
Structural Mechanisms Of Genome Flow In Bacteriophage T4 And Their Biomedical Applications
National Science Foundation
Grant: 0923873
Mechanism of ATP-driven DNA Packaging in Bacteriophage T4
Fields of Study
Keywords